IDiyas

For the Inventor, By the Inventor

Brussels, Belgium

Bernard Lethe

USPTO Granted Patents = 12


Average Co-Inventor Count = 6.9

ph-index = 6

Forward Citations = 142(Granted Patents)


Company Filing History:

goldMedal12 out of 525 
 
Ludwig Institute for Cancer Research Limited
 patents

Years Active: 1996-2011

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 7998483 - Lage-1 tumor associated nucleic acids (2011-08-16),
2. 6794131 - Lage-1 tumor associated nucleic acids (2004-09-21),
3. 6716809 - Mage-A3 peptides presented by HLA class molecules (2004-04-06),
4. 6669946 - METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HUMAN LEUKOCYTE ANTIGEN TYROSINASE DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS (2003-12-30),
5. 5843688 - Isolated tyrosinase derived peptides and uses thereof (1998-12-01),
6. 5763165 - Method for determining lung adenocarcinomas by assaying for one or more (1998-06-09),
7. 5763155 - Method for determining lung adenocarcinomas by assaying for one or more (1998-06-09),
8. 5744316 - Isolated, tyrosinase derived peptides and uses thereof (1998-04-28),
9. 5612201 - Isolated nucleic acid molecules useful in determining expression of a (1997-03-18),
10. 5530096 - Isolated, tyrosinase derived peptides and uses thereof (1996-06-25),
11. 5512437 - Method for determining head and neck squamous cell carcinomas, prostate (1996-04-30),
12. 5487974 - Method for detecting complexes containing human leukocyte antigen A2 (1996-01-30),

Title: The Innovations of Bernard Lethe

Introduction

Bernard Lethe is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his innovative work on tumor-associated nucleic acids. With a total of 12 patents to his name, Lethe has established himself as a key figure in the scientific community.

Latest Patents

Among his latest patents is the invention related to the LAGE-1 tumor-associated gene. This invention describes the LAGE-1 gene, including its fragments, allelic variants, and splice variants. Additionally, it encompasses polypeptides and fragments encoded by such genes, along with antibodies related to them. The methods and products provided in this patent are aimed at diagnosing and treating conditions characterized by the expression of a LAGE-1 gene product.

Career Highlights

Bernard Lethe is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work has been instrumental in understanding the genetic factors associated with cancer, paving the way for potential therapeutic applications.

Collaborations

Lethe has collaborated with notable colleagues in his field, including Thierry R Boon-Falleur and Vincent Brichard. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

Bernard Lethe's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and offers hope for advancements in cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…